Ivacure 6 mg (Tablet)

Unit Price: ৳ 10.00 (1 x 10: ৳ 100.00)

Strip Price: ৳ 100.00

Medicine Details

Category	Details
Generic	Ivermectin tablet
Company	Eskayef pharmaceuticals ltd
Also available as	Ivacure 3 mg tablet

Ivacure tablet is indicated for the treatment of strongyloidiasis, onchocerciasis, filariasis, scabies, and head lice.
Ivacure selectively binds to glutamate-gated chloride ion channels in invertebrates, leading to hyperpolarization and death of the parasite.
Dosage & Administration: Treatment for COVIO positive patients, prophylaxis, recommended dosage for strongyloidiasis and onchocerciasis.
Interaction may occur when co-administered with warfarin, resulting in increased INR.
Contraindicated in patients hypersensitive to any component of the product.
Side Effects: Adverse reactions related to Ivacure for strongyloidiasis and onchocerciasis.
Pregnancy & Lactation: Pregnancy category C, excreted in low concentrations in human milk, caution for nursing mothers.
Precautions & Warnings: Mazzotti reaction, ophthalmological reactions, hyperreactive onchodermatitis, and adverse reactions in patients heavily infected with Loa loa.
Use in Special Populations: Safety and effectiveness in pediatric patients weighing less than 15 kg not established, insufficient data for geriatric use.
Storage Conditions: Keep in a dry place, below 30°C, protect from light, keep out of the reach of children.

2 Tablets of Ivermectin 6 mg once daily for 5 days for COVIO positive patients.
Dosage guidelines for Ivermectin for strongyloidiasis based on body weight.
Recommended dosage of Ivermectin for onchocerciasis on an empty stomach with water.

Treatment of strongyloidiasis, onchocerciasis, filariasis, scabies, and head lice.

Ivermectin selectively binds and with high affinity to glutamate-gated chloride ion channels in invertebrates.

Pregnancy Category C, excreted in human milk in low concentrations, caution for nursing mothers.

Mazzotti reaction, ophthalmological reactions, hyperreactive onchodermatitis, and adverse reactions in patients heavily infected with Loa loa.

Safety and effectiveness in pediatric patients weighing less than 15 kg not established, insufficient data for geriatric use.

Keep in a dry place, below 30°C, protect from light, keep out of the reach of children.